Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for treating post stroke depression and application thereof

A stroke and drug technology, which is applied to the drug for the treatment of post-stroke depression and its application field, can solve the problems of long onset time and treatment time, long onset time and treatment course, and repeated symptoms, so as to shorten the course of treatment and reduce the Paradoxical phenomenon, the effect of maintaining the curative effect

Inactive Publication Date: 2014-12-17
上海市闸北区中医医院
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the onset time and treatment time are both longer, and once the drug is stopped, the symptoms are prone to recurrence or aggravation
To sum up, it can be seen that psychotropic drugs have certain defects, such as longer onset time and course of treatment, higher cost, and certain side effects, such as "paradoxical phenomenon of antipsychotic drugs" and "anticholinergic side effects"

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating post stroke depression and application thereof
  • Medicine for treating post stroke depression and application thereof
  • Medicine for treating post stroke depression and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1 The preparation of depression drug one after the stroke (1)

[0031] Twenty -25 copies of Danshen, 25 copies of Shijia Pu, 10 copies of Chuanxiong, 10 copies of Bai Zhi, 10 Yuanzhi, 5 copies of safflower, 15 copies of peach kernels, 17 copies of fragrant fragrant15 copies, 8 parts of green peel, conventional methods fry.

Embodiment 2

[0032] Example 2 The preparation of depression drug one after the stroke (2)

[0033] 35 copies of Danshen, 35 Shi Pu, 20 copies of Chuanxiong, 20 copies of Baiyan, 20 Yuanzhi, 15 red flowers, 5 copies of peach kernels, 5 copies of fragrant fragrance, 5 copies of Chaihu, 5 copies of coriander shells, broad tulipsFive copies and 4 parts of green peels, conventional methods fry.

Embodiment 3

[0034] Example 3 Preparation of depression drug one after stroke (3)

[0035] Twenty -25 copies of Danshen, 25 copies of Shijia Pu, 10 copies of Chuanxiong, 10 copies of Bai Zhi, 10 Yuanzhi, 5 copies of safflower, 5 copies of peach kernels, 5 copies of fragrant fragrance, 5 copies of Chaihu, 5 copies of coriander shells, broad tulips, broad tulipsFive copies and 4 parts of green peels, conventional methods fry.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating post stroke depression and an application thereof. The medicine is prepared from the following medicinal raw materials in parts by weight: 25-35 parts of salvia miltiorrhiza, 25-35 parts of rhizoma acori graminei, 10-20 parts of ligusticum wallichii, 10-20 parts of radix paeoniae alba, 10-20 parts of polygala tenuifolia, 5-15 parts of safflower carthamus, 5-15 parts of peach kernel, 7-17 parts of prepared rhizoma cyperi, 5-15 parts of radix bupleuri, 5-15 parts of fructus aurantii, 5-15 parts of radix curcumae, 4-8 parts of pericarpium citri reticulatae viride, 10-20 parts of endothelium corneum gigeriae galli, 25-35 parts of fructus cannabis, 25-35 parts of spina date seed and 25-35 parts of tuber fleeceflower stem. The invention further relates to a composition containing the medicine and fluoxetine hydrochloride. The medicine combined with antidepressant is capable of accelerating the drug effect taking speed, the dose can be controlled, the course of treatment can be shortened, the 'contradictory phenomena' and 'anticholinergic side effect' can be reduced, the effect of the medicine by combining comprehensive rehabilitation therapy is relatively remarkable in the treatment process, and the medicine is capable of gradually replacing the antidepressant in the later period of treatment.

Description

Technical field [0001] The present invention involves a traditional Chinese medicine preparation. Specifically, it is a drug and its application that treats depression after stroke. Background technique [0002] In addition to hemiplegia in patients with stroke patients, there are different degrees of cognitive and language dysfunction, and a series of changes in emotional behaviors are produced.Depression is the most common psychological barrier after stroke.It is called post-stoke depression (PSD).The clinical manifestations of mild depression are insomnia or sleep, life, decreased interest in learning, inconsistent attention, reduced speech, sadness, disappointment, excessive thoughts, etc.The manifestation of moderate depression is emotional instability, anxiety, loss of appetite, weight loss, reduction of speech, etc.Severe depression manifestations are despair or suicide, and do not take the initiative to eat, have no desire, slow thinking, and significantly reduced speech....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P25/24A61K35/37A61K31/137
Inventor 许江虹
Owner 上海市闸北区中医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products